This is probably the most complete and authoritative text now available
- BMJ
Coronary Heart Disease Epidemiology
From aetiology to public health
Second Edition
Edited by Michael Marmot and Paul Elliott
Price: £66.00 (Paperback)
ISBN-13: 978-0-19-852573-8
Publication date: 30 June 2005
952 pages, 2 halftones, numerous tables, graphs and line drawings, 240x168 mm
|
Ordering |
Individual customers:
order by phone, post, or fax
Teachers in UK and European schools (and FE colleges in
the UK):
order by phone, post,
or fax
|
| Reviews |
| - '...an invaluable guide to the epidemiology of CHD...[and] an extremely useful companion to students and researchers in CHD epidemiology, and to all of those interested in the latest developments in our understanding of the leading cause of death worldwide.' - Critical Public Health
- '... this book is a must have reference providing enough detail to establish a comprehensive knowledge base for epidemiologists who research cardiovascular disease and investigate the efficacy of preventive strategies.' - Doody's Journal
|
| Description | | - Comprehensive review of the subject from clinical, epidemiological, public health perspectives
- Many new authors and chapters reflecting the considerable change in the field alongside three classic chapters by Epstein, Rose and Morris.
- Contributions from international authorities in the field
- Covers disease aetiology, trends and public health policy
- Contains a new section on The Global Picture of CHD
- Many new chapters including those on diet, alcohol, metabolic syndrome, mental illness, psychophysiology, chronic infection, air pollution, temperature and gene-environment interactions, and inequalities
- Expanded themes including psychological, behavioural and social factors
| Coronary heart disease is the leading cause of death worldwide affecting millions of people in both developed and developing countries. The dual aims of this book are to review the well-established and emerging risk factors in coronary heart disease and to apply this knowledge to public health approaches to disease prevention. The book includes authoritative accounts of studies within a
single population and international studies, important areas of methodological development, trials to test preventive strategies, and the application of epidemiological and other knowledge to the development of public health policy for the prevention of widespread disease. It is an all-encompassing work containing contributions from the world authorities in the field.
The book is divided
into four sections. The introduction reviews advances in the understanding of, and the current status, of risk factors for CHD. Section 2 looks at recent global trends and emerging patterns of CHD morbidity and mortality in several countries, and includes chapters on work done under the auspices of WHO on the global burden of disease in relation to smoking and blood pressure. Section 3 focuses on
advances in understanding the aetiology of CHD with each chapter focused on a particular risk factor. Section 4 explores measures of prevention and intervention in terms of public health policy with specific examples from around the world.
|
Readership: Postgraduate students in epidemiology and public health and practising coronary heart disease epidemiologists, as well as public health policy makers and those involved in preventive medicine in the field of heart disease.
| Contents |
Section I: Introduction
1.
Coronary heart disease epidemiology: from aetiology to public health
,
Michael Marmot & Paul Elliott
2.
Contribution of epidemiology to understanding coronary heart disease (reprinted from the 1st edition)
,
Fredrick H. Epstein
3.
Established major coronary risk factors: historical overview
,
Jeremiah Stamler
4.
Current status: six established major risk factors - and low risk
,
Jeremiah Stamler, James D. Neaton, Dan Garside & Martha Daviglus
Section II: Global picture of coronary heart disease
II.I.
Worldwide trends
5.
US trends
,
Russell V. Luepker
6.
Coronary heart disease in Central and Eastern Europe and the former Soviet Union
,
Martin Bobak & Michael Marmot
7.
Trends in Asia
,
Hirotsugu Ueshima
8.
Developing countries
,
K. Srinath Reddy
9.
Coronary heart disease burden among persons of African origin
,
Richard S. Cooper
10.
Coronary heart disease mortality attributable to smoking: Global and regional estimates for 2000
,
Majid
11.
Ezzati & Alan D. Lopez
Blood pressure and the burden of coronary heart disease
,
Carlene M. M. Lawes, Stephen Vander Hoorn, Paul
12.
Elliott & Anthony Rodgers
Lipids and cholesterol
,
Malcolm Law & Anthony
13.
Rodgers
Trends in all-cause and cardiovascular mortality: A comparison between Belgium, the Netherlands and Denmark,
1950-1999
Jozef V. Joossens & Hugo Kesteloot
Section III: Aetiology
III.I.
Risk factors
14.
Dietary patterns and coronary heart disease risk
,
Thomas P. Erlinger & Lawrence J. Appel
15.
Antioxidants and cardiovascular disease
,
Edgar R. Miller & Lawrence J. Appel
16.
Serum homocysteine and coronary heart disease
,
David S. Wald, Malcolm Law, Joan Morris & Nicholas J. Wald
17.
Alcohol and coronary heart disease
,
Martin Bobak & Micheal Marmot
18.
Fish consumption, N-3 fatty acids amd coronary heart disease
,
Daan Kromhout
19.
Exercise versus heart attack: History of a hypothesis (reprinted from the 1st edition)
,
Jerry N. Morris
Addendum to Chapter 19
,
William L. Haskell
20.
Obesity
,
Alan R. Dyer, Jeremiah Stamler & Philip Greenland
21.
Metabolic syndrome, diabetes and coronary heart disease
,
Gang Hu, Qing Qiao & Jaako Tuomilehto
22.
Women and cardiovascular heart disease
,
Lewis H. Kuller
23.
Use of oral contraceptives
,
Neil R. Poulter
24.
Systematic review of prospective cohort studies of psychosocial factors in the aetiology and prognosis of coronary heart disease
,
Hannah Kuper, Michael Marmot & Harry Hemingway
25.
Mental illness and coronary heart disease
,
Stephen Stansfield & Farhat Rasul
26.
Psychophysiology
,
Andrew Steptoe
27.
Chronic infection and circulating markers of inflammation
,
Peter Whincup & John Danesh
28.
Coagulation, thrombosis and coronary heart disease
,
Thomas W. Meade & Peter K. MacCallum
29.
Air pollution
,
C. Arden Pope
30.
Seasonal variations in all-cause and cardiovascular mortality and the role of temperature
,
Mireille B. Toledano, Paul Elliott & Gavin Shaddick
31.
Gene-environment interaction and coronary artery disease: apolipoprotein E and smoking and the interleukin-6 gene and inflammation as examples
,
Steve E. Humphries
III.II.
Life course
32.
The developmental origins of coronary heart disease
,
David J. P. Barker
33.
Life course influences on coronary heart disease
,
George Davey Smith & John Lynch
34.
Emergence of risk factors in children
,
Darwin R. Labarthe
35.
Risk factors in the elderly
,
Johanna G. van der Bom & Diederick E. Grobbee
Section IV: Public health
36.
Strategies of prevention: the individual and the population (reprinted from the 1st edition)
,
G. Rose (deceased)
37.
Contributions to change: major risk factors and the potential for prevention
,
Robert Beaglehole & Annette Dobson
38.
Prevention of coronary heart diesase: Findings from the Nurses' Health Study and Health Professionals' Follow-Up Study
,
Frank B. Hu & Walter C. Willett
39.
Risk scores for management and the prevention of cardiovascular disease
,
David Wood & K. Kotseva
40.
Non-invasive measures of preclinical coronary heart disease
,
Philip Greenland
41.
Screening for future coronary heart disease
,
Nicholas J. Wald & Malcolm R. Law
42.
Screening for type 2 diabetes
,
Desmond G. Johnston, K. George M. M. Albetri, Ian F. Godsland, Mary Pierce & Sandra Shepperd
43.
Primary prevention of high blood pressure
,
Paul Elliott & Jeremiah Stamler
44.
The secondary prevention of cardiovascular disease
,
Sonia S. Anand, Eva Lonn & Salim Yusuf
45.
Smoke-free policies are an effective way to reduce heart disease rapidly
,
Caroline M. Fitchenberg & Stanton A. Glantz
46.
Nutrition Policy: national stratergies for dietary change
,
W. Philip T. James & Neville J. Rigby
47.
Lessening inequalities and effect on coronary heart disease
,
Margaret Whitehead & Michael Marmot
48.
Behaviour Change
,
Lucy J. Cooke, Jane Wardle & Martin Jarvis
49.
Contributions to change: treatment
,
Hugh Tunstall-Pedoe
50.
Intervention in high risk groups: hypertension
,
Peter S. Sever & Neil R. Poulter
51.
Community change and the role of public health
,
Pekka Puska
|
| Authors, editors,
and contributors |
Edited by Michael Marmot, Department of Epidemiology and Public Health, University College London, UK and
Paul Elliott, Professor of Epidemiology and Public Health, Imperial College of Science, Technology and Medicine, London, UK
| Contributors:K. George M. M. Alberti, Royal College of Physicians, London, UK
Sonia Anand, Department of Medicine, McMaster University, Ontario, Canada
Lawrence J. Appel, Johns Hopkins Medical Institutions, Baltimore, USA
David J. P. Barker, Southampton General Hospital, Southampton, UK
Robert Beaglehole, The University of Auckland, New Zealand and WHO, Geneva, Switzerland
Martin
Bobak, University College, London, UK
Richard S. Cooper, Loyola University Strich School of Medicine, Maywood, Illinois, USA
Lucy J. Cooke, Cancer Research UK Health Behaviour, University College, London UK
John Danesh, University of Cambridge, UK
George Davey Smith, University of Bristol, UK
Martha Daviglus, Department of Preventative Medicine, Northwestern University
Medical School, Chicago, USA
Annette Dobson, School of Population Health, University of Queensland, Australia
Alan R. Dyer, Northwestern University Medical School, Chicago, USA
Paul Elliott, Department of Epidemiology, Imperial College, London, UK
Fredrick H. Epstein, formerly at the Institute of Social and Preventive Medicine, University of Zurich, Switzerland
Thomas
Erlinger, Johns Hopkins Medical Institution, Baltimore, USA
Majid Ezzati, World Health Organisation, Washington, USA
Caroline M. Fitchenberg, Center for Tobacco Control Research and Education, University of California, San Francisco, USA
Dan Garside, Department of Preventative Medicine, Northwestern University Medical School, Chicago, USA
Stanton A. Glantz, Institute for Health
Policy Studies, University of California, San Francisco, USA
Ian F. Godsland, Department in Endochrinology and Metabolic Medicine, Imperial College, London, UK
Philip Greenland, Northwestern University Medical School, Chicago, USA
Diederick E. Grobbee, Julius Centre for Patient-Orientated Research, Utrecht, The Netherlands
William L. Haskell, Stanford Prevention Research
Center, Stanford Universty, California, USA
Harry Hemingway, University College Medical School, London, UK
Frank B. Hu, Brigham and Women^s Hospital and Harvard School of Public Health, Boston, USA
Gang Hu, National Public Health Institute, University of Helsinki, Finland
Steve E. Humphries, Royal Free and University College School of Medicine, London, UK
W. Philip T.
James, International Obesity Task force, London, UK
Martin J. Jarvis, Cancer Research UK Health Behaviour Unit, Department of Epidemiology and Public Health, University College, London, UK
Desmond G. Johnston, Department of Endocrinology and Metabolic Medicine, Imperial College London, UK
Jozef V. Joossens, School of Public Health, Katholieke Universeit Leuven, Belgium
Hugo
Kesteloot, School of Public Health, Katholieke Universeit Leuven, Belgium
Kornelia Kotseva, Cardiovascular Medicine, Imperial College London, UK
Daan Kromhout, National Institute of Public Health and The Environment, RIVM, Bilthoven, The Netherlands
Lewis H. Kuller, Department of Epidemiology, University of Pittsburgh, USA
Hannah E. Kuper, London School of Hygiene and Tropical
Medicine, University College London, UK
Darwin R. Labarthe, National Center for Chronic Disease Prevention, Atlanta, USA
Malcolm Law, Barts^ & The London Queen Mary^s School of Medicine, London, UK
Carlene M. M. Lawes, The University of Auckland, New Zealand
Eva Lonn, Department of Medicine, McMaster University, Ontario, Canada
Alan D. Lopez, World Health Organisation,
Geneva, Switzerland
Russell V. Luepker, University of Minnesota, Minneapolis, USA
John Lynch, Department of Epidemiology, University of Michigan, USA
Peter K. MacCallum, Wolfson Institute of Preventative Medicine, Barts and the London Queen Mary^s School of Medicine and Dentistry, London, UK
Michael Marmot, Department of Epidemiology & Public Health, University College, London,
UK
Thomas W. Meade, Wolfson Institute of Preventative Medicine, Barts and the London Queen Mary^s School of Medicine and Dentistry, London, UK
Edgar R. Miller, Welch Center for Prevention, Epidemiology and International Health, The Johns Hopkin Medical Institutions, Baltimore, USA
Joan Morris, Wolfson Institute of Preventative Medicine, Barts and the London Queen Mary^s School of
Medicine and Dentistry, London, UK
James D. Neaton, Department of Biostatistics, University of Minnesota, USA
Mary Pierce, School of Health and Social Studies, University of Warwick, Coventry, UK
C. Arden Pope, Department of Economics, Brigham Young University, Provo, Utah, USA
Neil R. Poulter, Imperial College, Faculty of Medicine, London, UK
Pekka M. Puska, National
Public Health Institute, Helsinki, Finland
Qing Qiao, Diabetes and Genetic Epidemiology, University of Helsinki, Finland
Farhat Rasul, Department of Psychiatry, Barts^ and the London, Queen Mary^s School of Medicine & Denistry, London, UK
K. Srinath Reddy, Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India
Neville Rigby, International Obesity
Task Force, London, UK
Anthony Rodgers, Department of Medicine, University of Auckland, New Zealand
G. Rose, formerly at the School of Hygiene and Tropical Medicine, London, UK
Peter S. Sever, Department of Clinical Pharmacology and Therapeutics, Imperial College, London, UK
Gavin Shaddick, Department of Mathematical Sciences, University of Bath, UK
Sasha Shepperd, Health
Sciences Centre for Professional Development, Department of Continuing Education, University of Oxford, UK
Jeremiah Stamler, Department of Preventative Medicine, Northwestern University Medical School, Chicago, Illinois, USA
Stephen Stansfield, Department of Psychiatry, Barts^ and the London Queen Mary^s School of Medicine, London, UK
Andrew Steptoe, Department of Epidemiology &
Public Health, University College, London, UK
Mireille Toledano, Department of Epidemiology and Public Health, Imperial College, London, UK
Jaako Tuomilehto, National Public Health Institute, Helsinki, Finland
Hugh Tunstall-Pedoe, Cardiovascular Epidemiology Unit, University of Dundee,UK
Hirotsugo Ueshima, Shiga University of Medicine, Shiga, Japan
Johanna G. van der Bom,
Julius Centre for Patient-Orientated Research, Utrecht, The Netherlands
Stephen Vander Hoorn, Faculty of Medical and Health Sciences, University of Auckland, New Zealand
David S. Wald, Wolfson Institute of Preventative Medicine, Barts and the London, Queen Mary^s School of Medicine and Dentistry, London, UK
Nicholas J. Wald, Department of Environmental and Preventative Medicine,
Barts^ & The London, Queen Mary^s School of Medicine and Dentistry, London, UK
Jane Wardle, Cancer Research UK Health Behaviour Unit, Department of Epidemiology amd Public Health, University College, London, UK
Peter Whincup, Department of Public Health Sciences, St George^s Hospital Medical School, London, UK
Margaret Whitehead, Department of Public Health, University of Liverpool,
UK
Walter C. Willett, Department of Nutrition, Harvard School of Public Health, Boston, USA
David A. Wood, Cardiovascular Medicine, Charing Cross Hospital, London, UK
Salim Yusuf, Department of Medicine, McMaster University, Ontario, Canada
|
The specification in this catalogue, including without
limitation price, format, extent, number of illustrations,
and month of publication, was as accurate as
possible at the time the catalogue was compiled.
Occasionally, due to the nature of some contractual restrictions, we
are unable to ship a specific product to a particular territory.
Jacket images are provisional and liable to change before publication.
|
VIEW BASKET
